Skip to main content

Table 1 Characteristics of the study population

From: Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register

Characteristics Primary prevention
n = 756,953
Secondary prevention
n = 447,423
Men, n (%) 396,028 (52.3) 274,891 (61.4)
Age, mean 63.7 ± 11.7 71.5 ± 9.5
Diabetes duration, mean years 7.4 ± 7.1 10.5 ± 8.4
HbA1c, mean mmol/mol 54.7 ± 14.6 55.5 ± 13.7
Diabetes medications, n (%) 560,539 (74.4) 350,387 (78.5)
Antiplateletsa, n (%) 171,114 (23.1) 316,290 (72.1)
Antihypertensives, n (%) 508,907 (68.6) 401,935 (90.9)
Systolic blood pressure, mean mmHg 137.2 ± 16.4 136.2 ± 16.9
Diastolic blood pressure, mean mmHg 78.5 ± 9.6 74.9 ± 9.8
Total cholesterol, mean mmol/l 5.4 ± 0.9 4.7 ± 1.0
LDL cholesterol, mean mmol/l 3.4 ± 0.7 2.7 ± 0.8
HDL cholesterol, mean mmol/l 1.3 ± 0.4 1.2 ± 0.3
Triglycerides, mean mmol/l 1.8 ± 0.9 1.8 ± 0.9
eGFR, mean ml/min/1.73 m² 85.6 ± 25.1 74.3 ± 25.0
Microalbuminuria, n (%) 92,812 (17.8) 77,698 (25.6)
Macroalbuminuria, n (%) 29,895 (5.7) 35,005 (11.3)
BMI, mean kg/m2 30.1 ± 5.4 29.7 ± 5.1
Physical activity < once a weekb, n (%) 105,300 (24.2) 87,486 (32.8)
Smokingc, n (%) 103,874 (17.1) 49,766 (13.7)
  1. Abbreviations: HbA1c, haemoglobin A1c; LDL, low-density lipoprotein; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; BMI, body mass index
  2. aATC code B01AC and N02BA01
  3. b30-minute walk or equivalent
  4. csmoking at least one cigarette or pipe per day, or quit smoking within three months